Detail Information of Microbiota Influence

General Information of Drug Transporter (DT)
DT ID DTD0189 Transporter Info
Gene Name SLC25A28
Transporter Name Mitochondrial iron transporter 2
Gene ID
81894
UniProt ID
Q96A46
Microbiota Influence of This DT (MBI)

Bacteria: Actinomycetota

   Genus: Mycobacterium

     Mycobacterium tuberculosis 

Microbe Info

Click to Show/Hide the Full List 8 Microbe Influence Related to This Species      

       Microbe Influence1

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [2], [3], [4]

Regulating Factor
Desferriexochelin 772MS

Detailed Description

 The compound Desferriexochelin 772MS Secreted by Mycobacterium tuberculosis str. Erdman has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence2

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [3], [4]

Regulating Factor
desA1

Detailed Description

 The protein desA1 of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence3

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [3], [4]

Regulating Factor
GAPDH

Detailed Description

 The protein GAPDH of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence4

 Co-transport of human SLC25A28 substrates/drugs in the health condition [1], [5], [4]

Regulating Factor
IrtAB ,

Detailed Description

 The protein IrtAB of Mycobacterium tuberculosis H37Rv has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence5

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [3], [4]

Regulating Factor
Rv0641

Detailed Description

 The protein Rv0641 of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence6

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [3], [4]

Regulating Factor
Rv0704

Detailed Description

 The protein Rv0704 of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence7

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [3], [4]

Regulating Factor
Rv1872c

Detailed Description

 The protein Rv1872c of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence8

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [3], [4]

Regulating Factor
tuf

Detailed Description

 The protein tuf of Mycobacterium tuberculosis H37Ra has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

Bacteria: Bacillota

   Genus: Staphylococcus

     Staphylococcus aureus 

Microbe Info

Click to Show/Hide the Full List 12 Microbe Influence Related to This Species      

       Microbe Influence1

 Co-transport of human SLC25A28 substrates/drugs in the health condition [6], [7], [4]

Regulating Factor
FhuCBG , ,

Detailed Description

 The protein FhuCBG of Staphylococcus aureus RN6390 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence2

 Sequestration of human SLC25A28 substrates/drugs in the health condition [6], [7], [4]

Regulating Factor
fhuD1

Detailed Description

 The protein fhuD1 of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence3

 Sequestration of human SLC25A28 substrates/drugs in the health condition [6], [7], [4]

Regulating Factor
fhud2

Detailed Description

 The protein fhud2 of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence4

 Sequestration of human SLC25A28 substrates/drugs in the health condition [8], [9], [4]

Regulating Factor
fhud2

Detailed Description

 The protein fhud2 of Staphylococcus aureus RN2564 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence5

 Co-transport of human SLC25A28 substrates/drugs in the health condition [3], [4], [6], [10]

Regulating Factor
HtsABC , ,

Detailed Description

 The protein HtsABC of Staphylococcus aureus RN6390 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence6

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [3], [4], [11]

Regulating Factor
isdA

Detailed Description

 The protein isdA of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence7

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [3], [4], [12]

Regulating Factor
isdA

Detailed Description

 The protein isdA of Staphylococcus aureus BB has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence8

 Sequestration of human SLC25A28 substrates/drugs in the health condition [3], [4], [13], [14]

Regulating Factor
isdA

Detailed Description

 The protein isdA of Staphylococcus aureus N100 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence9

 Co-transport of human SLC25A28 substrates/drugs in the health condition [4], [15], [16], [17]

Regulating Factor
MntABC , ,

Detailed Description

 The protein MntABC of Staphylococcus aureus subsp. aureus NCTC 8325 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence10

 Sequestration of human SLC25A28 substrates/drugs in the health condition [3], [4], [6], [10]

Regulating Factor
SfaABC , ,

Detailed Description

 The protein SfaABC of Staphylococcus aureus RN6390 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence11

 Co-transport of human SLC25A28 substrates/drugs in the health condition [3], [4], [6], [18]

Regulating Factor
SirABC , ,

Detailed Description

 The protein SirABC of Staphylococcus aureus subsp. aureus RN4220 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence12

 Co-transport of human SLC25A28 substrates/drugs in the health condition [3], [4], [6], [19]

Regulating Factor
SstABCD , , ,

Detailed Description

 The protein SstABCD of Staphylococcus aureus W has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

     Staphylococcus epidermidis 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence1

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [3], [4], [12]

Regulating Factor
Tpn

Detailed Description

 The protein tpn of Staphylococcus epidermidis 138 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence2

 Sequestration of human SLC25A28 substrates/drugs in the health condition [3], [4], [13], [14]

Regulating Factor
Tpn

Detailed Description

 The protein tpn of Staphylococcus epidermidis 2 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

   Genus: Streptococcus

     Streptococcus agalactiae 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence1

 Co-transport of human SLC25A28 substrates/drugs in the health condition [13], [20], [4]

Regulating Factor
FhuCDB , ,

Detailed Description

 The protein FhuCDB of Streptococcus agalactiae A909 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

Bacteria: Campylobacterota

   Genus: Campylobacter

     Campylobacter coli 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence1

 Sequestration of human SLC25A28 substrates/drugs in the health condition [3], [4], [21], [22], [23]

Regulating Factor
cfrB

Detailed Description

 The protein cfrB of Campylobacter coli W13A has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

     Campylobacter jejuni 

Microbe Info

Click to Show/Hide the Full List 5 Microbe Influence Related to This Species      

       Microbe Influence1

 Sequestration of human SLC25A28 substrates/drugs in the health condition [3], [4], [21], [22], [24]

Regulating Factor
cfrA

Detailed Description

 The protein cfrA of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence2

 Sequestration of human SLC25A28 substrates/drugs in the health condition [3], [4], [21], [22], [23]

Regulating Factor
cfrB

Detailed Description

 The protein cfrB of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence3

 Sequestration of human SLC25A28 substrates/drugs in the health condition [3], [4], [21], [22], [25]

Regulating Factor
ctuA

Detailed Description

 The protein ctuA of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence4

 Co-transport of human SLC25A28 substrates/drugs in the health condition [21], [22], [26], [4]

Regulating Factor
feoB

Detailed Description

 The protein feoB of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence5

 Sequestration of human SLC25A28 substrates/drugs in the health condition [21], [27], [4]

Regulating Factor
p19

Detailed Description

 The protein p19 of Campylobacter jejuni subsp. jejuni NCTC 11168 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

Bacteria: Cyanobacteriota

   Genus: Synechocystis

     Synechocystis sp. PCC 6803 

Microbe Info

Click to Show/Hide the Full List 4 Microbe Influence Related to This Species      

       Microbe Influence1

 Sequestration of human SLC25A28 substrates/drugs in the health condition [28], [29], [4]

Regulating Factor
futA1

Detailed Description

 The protein futa1 of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence2

 Sequestration of human SLC25A28 substrates/drugs in the health condition [28], [29], [4]

Regulating Factor
futA2

Detailed Description

 The protein futa2 of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence3

 Sequestration of human SLC25A28 substrates/drugs in the health condition [28], [29], [4]

Regulating Factor
futB

Detailed Description

 The protein futb of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence4

 Sequestration of human SLC25A28 substrates/drugs in the health condition [28], [30], [4]

Regulating Factor
sll1878

Detailed Description

 The protein sll1878 of Synechocystis sp. PCC 6803 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

Bacteria: Pseudomonadota

   Genus: Acinetobacter

     Acinetobacter baumannii 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence1

 Co-transport of human SLC25A28 substrates/drugs in the health condition [31], [3], [4]

Regulating Factor
tonB3

Detailed Description

 The protein tonB3 of Acinetobacter baumannii ATCC 19606 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

   Genus: Escherichia

     Escherichia coli 

Microbe Info

Click to Show/Hide the Full List 12 Microbe Influence Related to This Species      

       Microbe Influence1

 Sequestration of human SLC25A28 substrates/drugs in the health condition [28], [32], [3], [4]

Regulating Factor
efeO

Detailed Description

 The protein efeO of Escherichia coli Nissle 1917 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence2

 Co-transport of human SLC25A28 substrates/drugs in the health condition [28], [33], [4]

Regulating Factor
efeU

Detailed Description

 The protein efeU of Escherichia coli O157:H7 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence3

 Co-transport of human SLC25A28 substrates/drugs in the health condition [28], [32], [4]

Regulating Factor
efeU

Detailed Description

 The protein efeU of Escherichia coli Nissle 1917 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence4

 Co-transport of human SLC25A28 substrates/drugs in the health condition [13], [34], [4]

Regulating Factor
fecA

Detailed Description

 The protein fecA of Escherichia coli UT5600 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence5

 Sequestration of human SLC25A28 substrates/drugs in the health condition [13], [35], [4]

Regulating Factor
feoA

Detailed Description

 The protein feoA of Escherichia coli str. K-12 substr. MC4100 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence6

 Co-transport of human SLC25A28 substrates/drugs in the health condition [13], [35], [4]

Regulating Factor
feoB

Detailed Description

 The protein feoB of Escherichia coli str. K-12 substr. MC4100 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence7

 Co-transport of human SLC25A28 substrates/drugs in the health condition [36], [37], [4]

Regulating Factor
fhuA

Detailed Description

 The protein fhuA of Escherichia coli K-12 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence8

 Co-transport of human SLC25A28 substrates/drugs in the health condition [36], [38], [4]

Regulating Factor
fhuB

Detailed Description

 The protein fhuB of Escherichia coli DH5[alpha] has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence9

 Co-transport of human SLC25A28 substrates/drugs in the health condition [36], [39], [4]

Regulating Factor
fhuC

Detailed Description

 The protein fhuC of Escherichia coli AB2847 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence10

 Sequestration of human SLC25A28 substrates/drugs in the health condition [36], [40], [4]

Regulating Factor
fhuD

Detailed Description

 The protein fhuD of Escherichia coli BL21(DE3) has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence11

 Co-transport of human SLC25A28 substrates/drugs in the health condition [41], [4]

Regulating Factor
IroA , , , ,

Detailed Description

 The protein IroA of Escherichia coli CFT073 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence12

 Sequestration of human SLC25A28 substrates/drugs in the health condition [13], [42], [3], [4]

Regulating Factor
iroN

Detailed Description

 The protein iroN of Escherichia coli O18:H7 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

   Genus: Haemophilus

     Haemophilus influenzae 

Microbe Info

Click to Show/Hide the Full List 3 Microbe Influence Related to This Species      

       Microbe Influence1

 Co-transport of human SLC25A28 substrates/drugs in the health condition [13], [43], [4]

Regulating Factor
FhuCDB , ,

Detailed Description

 The protein FhuCDB of Haemophilus influenzae R2866 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence2

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [3], [4], [12], [44]

Regulating Factor
tbpA

Detailed Description

 The protein tbpA of Haemophilus influenzae type b has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence3

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [3], [4], [12], [44]

Regulating Factor
tbpB

Detailed Description

 The protein tbpB of Haemophilus influenzae type b has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

   Genus: Klebsiella

     Klebsiella pneumoniae 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence1

 Co-transport of human SLC25A28 substrates/drugs in the health condition [28], [45], [4]

Regulating Factor
feoC

Detailed Description

 The protein feoc of Klebsiella pneumoniae has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

   Genus: Moraxella

     Moraxella catarrhalis 

Microbe Info

Click to Show/Hide the Full List 4 Microbe Influence Related to This Species      

       Microbe Influence1

 Sequestration of human SLC25A28 substrates/drugs in the health condition [8], [46], [3], [4]

Regulating Factor
lbpA

Detailed Description

 The protein lbpa of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence2

 Sequestration of human SLC25A28 substrates/drugs in the health condition [8], [46], [3], [4]

Regulating Factor
lbpB

Detailed Description

 The protein lbpb of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence3

 Sequestration of human SLC25A28 substrates/drugs in the health condition [8], [46], [3], [4]

Regulating Factor
tbpA

Detailed Description

 The protein tbpa of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence4

 Sequestration of human SLC25A28 substrates/drugs in the health condition [8], [46], [3], [4]

Regulating Factor
tbpB

Detailed Description

 The protein tbpb of Moraxella catarrhalis has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

   Genus: Neisseria

     Neisseria gonorrhoeae 

Microbe Info

Click to Show/Hide the Full List 3 Microbe Influence Related to This Species      

       Microbe Influence1

 Sequestration of human SLC25A28 substrates/drugs in the health condition [13], [47], [3], [4]

Regulating Factor
lbpA

Detailed Description

 The protein lbpA of Neisseria gonorrhoeae FA19 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence2

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [3], [4], [12], [44]

Regulating Factor
tbpA

Detailed Description

 The protein tbpa of Neisseria gonorrhoeae has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence3

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [3], [4], [12], [44]

Regulating Factor
tbpB

Detailed Description

 The protein tbpb of Neisseria gonorrhoeae has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

     Neisseria meningitidis 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence1

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [3], [4], [12], [44]

Regulating Factor
tbp1

Detailed Description

 The protein tbp1 of Neisseria meningitidis has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence2

 Sequestration of human SLC25A28 substrates/drugs in the health condition [1], [3], [4], [12], [44]

Regulating Factor
tbpB

Detailed Description

 The protein tbpb of Neisseria meningitidis has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

   Genus: Pseudomonas

     Pseudomonas aeruginosa 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence1

 Sequestration of human SLC25A28 substrates/drugs in the health condition [48], [3], [4]

Regulating Factor
tonB

Detailed Description

 The protein tonB of Pseudomonas aeruginosa K199 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence2

 Sequestration of human SLC25A28 substrates/drugs in the health condition [49], [3], [4]

Regulating Factor
TonB1

Detailed Description

 The protein TonB1 of Pseudomonas aeruginosa K1040 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

   Genus: Salmonella

     Salmonella enterica 

Microbe Info

Click to Show/Hide the Full List 10 Microbe Influence Related to This Species      

       Microbe Influence1

 Sequestration of human SLC25A28 substrates/drugs in the health condition [50], [51], [4]

Regulating Factor
Ferrioxamine B

Detailed Description

 The compound Ferrioxamine B Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence2

 Sequestration of human SLC25A28 substrates/drugs in the health condition [50], [51], [4]

Regulating Factor
Ferrioxamine E

Detailed Description

 The compound Ferrioxamine E Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence3

 Sequestration of human SLC25A28 substrates/drugs in the health condition [50], [51], [4]

Regulating Factor
Ferrioxamine G1

Detailed Description

 The compound Ferrioxamine G1 Secreted by Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence4

 Co-transport of human SLC25A28 substrates/drugs in the health condition [52], [53], [3], [4]

Regulating Factor
fepD

Studied Tissue

 Intestine

In Vivo Model

 C3H/HeOuJ mice

Detailed Description

 The protein fepD of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence5

 Co-transport of human SLC25A28 substrates/drugs in the health condition [28], [54], [4]

Regulating Factor
feoA

Detailed Description

 The protein feoA of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence6

 Co-transport of human SLC25A28 substrates/drugs in the health condition [13], [55], [4]

Regulating Factor
feoB

Detailed Description

 The protein feoB of Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence7

 Sequestration of human SLC25A28 substrates/drugs in the health condition [28], [54], [4]

Regulating Factor
feoB

Detailed Description

 The protein feoB of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence8

 Co-transport of human SLC25A28 substrates/drugs in the health condition [28], [54], [4]

Regulating Factor
feoC

Detailed Description

 The protein feoC of Salmonella enterica subsp. enterica serovar Typhimurium str. 14028S has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence9

 Co-transport of human SLC25A28 substrates/drugs in the health condition [52], [53], [4]

Regulating Factor
SitABCD , , ,

Detailed Description

 The protein SitABCD of Salmonella enterica subsp. enterica serovar Typhimurium JF2043 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence10

 Co-transport of human SLC25A28 substrates/drugs in the health condition [13], [55], [3], [4]

Regulating Factor
tonB

Detailed Description

 The protein tonB of Salmonella enterica subsp. enterica serovar Typhimurium str. ATCC 14028 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

   Genus: Serratia

     Serratia marcescens 

Microbe Info

Click to Show/Hide the Full List 3 Microbe Influence Related to This Species      

       Microbe Influence1

 Sequestration of human SLC25A28 substrates/drugs in the health condition [28], [29], [56], [4]

Regulating Factor
sfuA

Detailed Description

 The protein sfua of Serratia marcescens has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence2

 Co-transport of human SLC25A28 substrates/drugs in the health condition [28], [29], [56], [4]

Regulating Factor
sfuB

Detailed Description

 The protein sfub of Serratia marcescens has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence3

 Co-transport of human SLC25A28 substrates/drugs in the health condition [28], [29], [56], [4]

Regulating Factor
sfuC

Detailed Description

 The protein sfuc of Serratia marcescens has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

   Genus: Shigella

     Shigella flexneri 

Microbe Info

Click to Show/Hide the Full List 4 Microbe Influence Related to This Species      

       Microbe Influence1

 Sequestration of human SLC25A28 substrates/drugs in the health condition [13], [57], [4]

Regulating Factor
fec

Detailed Description

 The protein fec of Shigella flexneri 2a has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence2

 Co-transport of human SLC25A28 substrates/drugs in the health condition [13], [58], [4]

Regulating Factor
feoB

Detailed Description

 The protein feoB of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence3

 Co-transport of human SLC25A28 substrates/drugs in the health condition [13], [58], [4]

Regulating Factor
sitA

Detailed Description

 The protein sitA of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence4

 Co-transport of human SLC25A28 substrates/drugs in the health condition [15], [16], [58], [4]

Regulating Factor
SitABCD , , ,

Detailed Description

 The protein SitABCD of Shigella flexneri SA100 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

   Genus: Vibrio

     Vibrio anguillarum 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence1

 Co-transport of human SLC25A28 substrates/drugs in the health condition [50], [59], [4]

Regulating Factor
fatA

Detailed Description

 The protein fata of Vibrio anguillarum 775 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence2

 Co-transport of human SLC25A28 substrates/drugs in the health condition [50], [59], [4]

Regulating Factor
fatB

Detailed Description

 The protein fatb of Vibrio anguillarum 775 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

     Vibrio cholerae 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence1

 Co-transport of human SLC25A28 substrates/drugs in the health condition [13], [60], [4]

Regulating Factor
Fbp

Detailed Description

 The protein Fbp of Vibrio cholerae O395 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence2

 Co-transport of human SLC25A28 substrates/drugs in the health condition [13], [60], [4]

Regulating Factor
feo

Detailed Description

 The protein feo of Vibrio cholerae O395 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

   Genus: Yersinia

     Yersinia enterocolitica 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence1

 Sequestration of human SLC25A28 substrates/drugs in the health condition [50], [61], [4]

Regulating Factor
fyuA

Detailed Description

 The protein fyuA of Yersinia enterocolitica WA-C has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

     Yersinia pestis 

Microbe Info

Click to Show/Hide the Full List 5 Microbe Influence Related to This Species      

       Microbe Influence1

 Co-transport of human SLC25A28 substrates/drugs in pneumonic plague condition [62], [4]

Regulating Factor
feo

Studied Phenotype

 Pneumonic plague [ICD11: 1B93.2]

Studied Tissue

 Lung

In Vivo Model

 Swiss Webster mice

Detailed Description

 The protein feo of Yersinia pestis KIM6 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence2

 Sequestration of human SLC25A28 substrates/drugs in the health condition [13], [63], [4]

Regulating Factor
psn

Studied Tissue

 Lung

In Vivo Model

 Swiss Webster mice

Detailed Description

 The protein psn of Yersinia pestis KIM5 has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

       Microbe Influence3

 Co-transport of human SLC25A28 substrates/drugs in the health condition [13], [64], [4]

Regulating Factor
YfeAB ,

Studied Tissue

 Blood

In Vivo Model

 Swiss Webster mice

Detailed Description

 The protein YfeAB of Yersinia pestis KIM5 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence4

 Co-transport of human SLC25A28 substrates/drugs in the health condition [62], [4]

Regulating Factor
YfeABCD , , ,

Studied Tissue

 Lung

In Vivo Model

 Swiss Webster mice

Detailed Description

 The protein YfeABCD of Yersinia pestis KIM6 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence5

 Co-transport of human SLC25A28 substrates/drugs in the health condition [15], [16], [64], [4]

Regulating Factor
YfeABCD , , ,

Detailed Description

 The protein YfeABCD of Yersinia pestis KIM5-2031.11+ has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

Bacteria: Spirochaetota

   Genus: Treponema

     Treponema pallidum 

Microbe Info

Click to Show/Hide the Full List 1 Microbe Influence Related to This Species      

       Microbe Influence1

 Sequestration of human SLC25A28 substrates/drugs in the health condition [65], [3], [4]

Regulating Factor
troA

Detailed Description

 The protein troA of Treponema pallidum subsp. pallidum str. Nichols has been reported to sequester the substrate/drug of SLC25A28, which may affects its substrate/drug distribution in the body.

Fungi: Ascomycota

   Genus: Candida

     Candida albicans 

Microbe Info

Click to Show/Hide the Full List 2 Microbe Influence Related to This Species      

       Microbe Influence1

 Co-transport of human SLC25A28 substrates/drugs in the health condition [52], [66], [3], [4]

Regulating Factor
Sit1p

Studied Tissue

 Blood

In Vivo Model

 BALB/c mice

Detailed Description

 The protein Sit1p of Candida albicans CAF2-1 has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.

       Microbe Influence2

 Co-transport of human SLC25A28 substrates/drugs in the health condition [52], [67], [4]

Regulating Factor
CaFTR1

Detailed Description

 The protein caftr1 of Candida albicans has been reported to transport similar substrates/drugs of SLC25A28, which affects the distribution of its substrate/drug in vivo.
References
1 Mycobacterium tuberculosis acquires iron by cell-surface sequestration and internalization of human holo-transferrin. Nat Commun. 2014 Aug 28;5:4730.
2 Exochelins of Mycobacterium tuberculosis remove iron from human iron-binding proteins and donate iron to mycobactins in the M. tuberculosis cell wall. J Exp Med. 1996 Apr 1;183(4):1527-32.
3 Iron, copper, zinc, and manganese transport and regulation in pathogenic Enterobacteria: correlations between strains, site of infection and the relative importance of the different metal transport systems for virulence. Front Cell Infect Microbiol. 2013 Dec 5;3:90.
4 Iron and manganese transport in mammalian systems. Biochim Biophys Acta Mol Cell Res. 2021 Jan;1868(1):118890.
5 The Mycobacterium tuberculosis high-affinity iron importer, IrtA, contains an FAD-binding domain. J Bacteriol. 2010 Feb;192(3):861-9.
6 Siderophore-mediated iron acquisition in the staphylococci. J Inorg Biochem. 2010 Mar;104(3):282-8.
7 FhuD1, a ferric hydroxamate-binding lipoprotein in Staphylococcus aureus: a case of gene duplication and lateral transfer. J Biol Chem. 2004 Dec 17;279(51):53152-9.
8 The commensal lifestyle of Staphylococcus aureus and its interactions with the nasal microbiota. Nat Rev Microbiol. 2017 Oct 12;15(11):675-687.
9 The role of FhuD2 in iron(III)-hydroxamate transport in Staphylococcus aureus. Demonstration that FhuD2 binds iron(III)-hydroxamates but with minimal conformational change and implication of mutations on transport. J Biol Chem. 2003 Dec 12;278(50):49890-900.
10 Characterization of staphyloferrin A biosynthetic and transport mutants in Staphylococcus aureus. Mol Microbiol. 2009 May;72(4):947-63.
11 Transferrin binding in Staphylococcus aureus: involvement of a cell wall-anchored protein. Mol Microbiol. 2002 Mar;43(6):1603-14.
12 The staphylococcal transferrin-binding protein is a cell wall glyceraldehyde-3-phosphate dehydrogenase. Infect Immun. 1999 Mar;67(3):1086-92.
13 Sequestration and scavenging of iron in infection. Infect Immun. 2013 Oct;81(10):3503-14.
14 Staphylococci express a receptor for human transferrin: identification of a 42-kilodalton cell wall transferrin-binding protein. Infect Immun. 1994 Sep;62(9):3850-8.
15 Manganese homeostasis and utilization in pathogenic bacteria. Mol Microbiol. 2015 Jul;97(2):216-28.
16 Manganese transport and the role of manganese in virulence. Annu Rev Microbiol. 2006;60:187-209.
17 MntR modulates expression of the PerR regulon and superoxide resistance in Staphylococcus aureus through control of manganese uptake. Mol Microbiol. 2002 Jun;44(5):1269-86.
18 Involvement of SirABC in iron-siderophore import in Staphylococcus aureus. J Bacteriol. 2004 Dec;186(24):8356-62.
19 Molecular cloning and analysis of a putative siderophore ABC transporter from Staphylococcus aureus. Infect Immun. 2000 Nov;68(11):6281-8.
20 Evidence for siderophore-dependent iron acquisition in group B streptococcus. Mol Microbiol. 2006 Jan;59(2):707-21.
21 Metal homeostasis in pathogenic Epsilonproteobacteria: mechanisms of acquisition, efflux, and regulation. Metallomics. 2021 Jan 16;13(1):mfaa002.
22 Nutrient acquisition and metabolism by Campylobacter jejuni. Front Cell Infect Microbiol. 2012 Feb 7;2:5.
23 Identification and characterization of a new ferric enterobactin receptor, CfrB, in Campylobacter. J Bacteriol. 2010 Sep;192(17):4425-35.
24 Iron acquisition and regulation in Campylobacter jejuni. J Bacteriol. 2004 Jul;186(14):4714-29.
25 Utilization of lactoferrin-bound and transferrin-bound iron by Campylobacter jejuni. J Bacteriol. 2008 Mar;190(6):1900-11.
26 Major role for FeoB in Campylobacter jejuni ferrous iron acquisition, gut colonization, and intracellular survival. Infect Immun. 2006 Oct;74(10):5433-44.
27 Structure and function of P19, a high-affinity iron transporter of the human pathogen Campylobacter jejuni. J Mol Biol. 2010 Aug 27;401(4):590-604.
28 Bacterial ferrous iron transport: the Feo system. FEMS Microbiol Rev. 2016 Mar;40(2):273-98.
29 Iron-binding activity of FutA1 subunit of an ABC-type iron transporter in the cyanobacterium Synechocystis sp. Strain PCC 6803. Plant Cell Physiol. 2001 Aug;42(8):823-7.
30 Genes essential to iron transport in the cyanobacterium Synechocystis sp. strain PCC 6803. J Bacteriol. 2001 May;183(9):2779-84.
31 Contribution of Active Iron Uptake to Acinetobacter baumannii Pathogenicity. Infect Immun. 2019 Mar 25;87(4):e00755-18.
32 A new ferrous iron-uptake transporter, EfeU (YcdN), from Escherichia coli. Mol Microbiol. 2006 Oct;62(1):120-31.
33 EfeUOB (YcdNOB) is a tripartite, acid-induced and CpxAR-regulated, low-pH Fe2+ transporter that is cryptic in Escherichia coli K-12 but functional in E. coli O157:H7. Mol Microbiol. 2007 Aug;65(4):857-75.
34 Structural basis of gating by the outer membrane transporter FecA. Science. 2002 Mar 1;295(5560):1715-9.
35 Characterization of the ferrous iron uptake system of Escherichia coli. J Bacteriol. 1993 Oct;175(19):6212-9.
36 Iron uptake mechanisms and their regulation in pathogenic bacteria. Int J Med Microbiol. 2001 May;291(2):67-79.
37 Siderophore-mediated iron transport: crystal structure of FhuA with bound lipopolysaccharide. Science. 1998 Dec 18;282(5397):2215-20.
38 Transmembrane topology of the two FhuB domains representing the hydrophobic components of bacterial ABC transporters involved in the uptake of siderophores, haem and vitamin B12. Microbiology (Reading). 1998 Oct;144 ( Pt 10):2759-2769.
39 Iron(III) hydroxamate transport in Escherichia coli K-12: FhuB-mediated membrane association of the FhuC protein and negative complementation of fhuC mutants. J Bacteriol. 1992 Apr;174(7):2305-11.
40 The structure of the ferric siderophore binding protein FhuD complexed with gallichrome. Nat Struct Biol. 2000 Apr;7(4):287-91.
41 The pathogen-associated iroA gene cluster mediates bacterial evasion of lipocalin 2. Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16502-7.
42 The siderophore receptor IroN, but not the high-pathogenicity island or the hemin receptor ChuA, contributes to the bacteremic step of Escherichia coli neonatal meningitis. Infect Immun. 2004 Feb;72(2):1216-20.
43 Identification of a siderophore utilization locus in nontypeable Haemophilus influenzae. BMC Microbiol. 2010 Apr 15;10:113.
44 Iron piracy: acquisition of transferrin-bound iron by bacterial pathogens. Mol Microbiol. 1994 Dec;14(5):843-50.
45 NMR structure note: the ferrous iron transport protein C (FeoC) from Klebsiella pneumoniae. J Biomol NMR. 2012 Jun;53(2):161-5.
46 Moraxella catarrhalis: a review of an important human mucosal pathogen. Microbes Infect. 2000 Apr;2(5):547-59.
47 Characterization of lbpA, the structural gene for a lactoferrin receptor in Neisseria gonorrhoeae. Infect Immun. 1995 Aug;63(8):2958-67.
48 The Pseudomonas aeruginosa tonB gene encodes a novel TonB protein. Microbiology (Reading). 1996 Jun;142 ( Pt 6):1449-1458.
49 Mutational analysis of the TonB1 energy coupler of Pseudomonas aeruginosa. J Bacteriol. 2002 Mar;184(6):1503-13.
50 Iron metabolism in pathogenic bacteria. Annu Rev Microbiol. 2000;54:881-941.
51 Ferrioxamine-mediated Iron(III) utilization by Salmonella enterica. Appl Environ Microbiol. 1999 Apr;65(4):1610-8.
52 Transition metal ions at the crossroads of mucosal immunity and microbial pathogenesis. Front Cell Infect Microbiol. 2014 Jan 24;4:2.
53 Biosynthesis and IroC-dependent export of the siderophore salmochelin are essential for virulence of Salmonella enterica serovar Typhimurium. Mol Microbiol. 2008 Mar;67(5):971-83.
54 Lon-mediated proteolysis of the FeoC protein prevents Salmonella enterica from accumulating the Fe(II) transporter FeoB under high-oxygen conditions. J Bacteriol. 2015 Jan 1;197(1):92-8.
55 Contribution of TonB- and Feo-mediated iron uptake to growth of Salmonella typhimurium in the mouse. Infect Immun. 1996 Nov;64(11):4549-56.
56 Nucleotide sequences of the sfuA, sfuB, and sfuC genes of Serratia marcescens suggest a periplasmic-binding-protein-dependent iron transport mechanism. J Bacteriol. 1990 Feb;172(2):572-8.
57 Ferric dicitrate transport system (Fec) of Shigella flexneri 2a YSH6000 is encoded on a novel pathogenicity island carrying multiple antibiotic resistance genes. Infect Immun. 2001 Oct;69(10):6012-21.
58 Contribution of the Shigella flexneri Sit, Iuc, and Feo iron acquisition systems to iron acquisition in vitro and in cultured cells. Infect Immun. 2003 Apr;71(4):1919-28.
59 The AngR protein and the siderophore anguibactin positively regulate the expression of iron-transport genes in Vibrio anguillarum. Mol Microbiol. 1996 Oct;22(1):127-34.
60 Characterization of ferric and ferrous iron transport systems in Vibrio cholerae. J Bacteriol. 2006 Sep;188(18):6515-23.
61 Purification of yersiniabactin: a siderophore and possible virulence factor of Yersinia enterocolitica. J Gen Microbiol. 1993 Sep;139(9):2159-65.
62 The Yfe and Feo transporters are involved in microaerobic growth and virulence of Yersinia pestis in bubonic plague. Infect Immun. 2012 Nov;80(11):3880-91.
63 The yersiniabactin transport system is critical for the pathogenesis of bubonic and pneumonic plague. Infect Immun. 2010 May;78(5):2045-52.
64 The Yfe system of Yersinia pestis transports iron and manganese and is required for full virulence of plague. Mol Microbiol. 1999 Apr;32(2):403-14.
65 The general transition metal (Tro) and Zn2+ (Znu) transporters in Treponema pallidum: analysis of metal specificities and expression profiles. Mol Microbiol. 2007 Jul;65(1):137-52.
66 The siderophore iron transporter of Candida albicans (Sit1p/Arn1p) mediates uptake of ferrichrome-type siderophores and is required for epithelial invasion. Infect Immun. 2002 Sep;70(9):5246-55.
67 A high-affinity iron permease essential for Candida albicans virulence. Science. 2000 May 12;288(5468):1062-4.

If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.